Keri Ramsey, BSN, is Clinical Co-Director of the Center for Rare Childhood Disorders at the Translational Genomics Research Institute (TGen). The goal of the Center is to use the latest advances in genetic sequencing to identify or provide insight into the cause of unexplained rare childhood disorders.
Keri originally started working at TGen in 2003 as Lead Technologist and Center Coordinator for the NINDS/NIMH Microarray Consortium. The Consortium supported gene expression profiling of the nervous system through the application of microarray technologies and provided reagents, services, and training to the neuroscience community, on a fee-for-service basis.
In 2007 she left TGen and obtained her nursing degree at Arizona State University. She spent four years working as a Certified Critical Care Nurse in the Neuro Intensive Care Unit at Banner Good Samaritan (now Banner University Medical Center Phoenix).
Keri returned to TGen in 2013 as a clinical research coordinator at The Center. In her current role as Clinical Co-Director, Keri works on several research studies. The largest of these studies uses next-generation sequencing to diagnose rare childhood disorders. Another study aims to identify genetic modifiers affecting Tuberous Sclerosis (TSC) patients and their parents. She is also the lead coordinator in a pharmaceutical study focused on improving the quality of life in girls and women with Rett syndrome. Keri screens patients for enrollment, consents families, and obtains tissue specimens. She updates families on their progress in the study and assists in returning research results.
